Quick Answer
RxSight, Inc. reported Total Revenue of $134.48 million for fiscal year 2025.
RxSight, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $134.48M -3.9% |
$139.93M +57.1% |
$89.08M +81.8% |
$49.01M +116.9% |
$22.59M +53.9% |
$14.68M |
| Revenue (ASC 606) | $134.48M -3.9% |
$139.93M +57.1% |
$89.08M +81.8% |
$49.01M +116.9% |
$22.59M +53.9% |
$14.68M |
| Net Income | -$38.94M -41.8% |
-$27.45M +43.5% |
-$48.61M +27.2% |
-$66.76M -37.1% |
-$48.69M -276.6% |
$27.57M |
| Diluted EPS | -$0.95 -33.8% |
-$0.71 +49.6% |
-$1.41 +41.5% |
-$2.41 +32.5% |
-$3.57 -2480.0% |
$0.15 |
| Total Assets | $311.81M -2.1% |
$318.56M +74.5% |
$182.55M +21.6% |
$150.16M -22.1% |
$192.72M +91.4% |
$100.68M |
| Cash and Equivalents | $19.95M +19.4% |
$16.71M +72.4% |
$9.69M -18.1% |
$11.83M -51.4% |
$24.36M +74.1% |
$13.99M |
| Long-Term Debt | — | — | $0.00 -100.0% |
$40.17M +1.0% |
$39.76M +63.0% |
$24.40M |
| Stockholders Equity | $275.68M -2.0% |
$281.24M +75.4% |
$160.36M +78.4% |
$89.90M -35.0% |
$138.24M +132.1% |
-$430.59M -2.6% |
| R&D Expense | $38.55M +12.2% |
$34.37M +18.3% |
$29.05M +11.8% |
$25.98M +6.0% |
$24.50M +11.7% |
$21.93M |
| Operating Income | -$48.19M -30.7% |
-$36.86M +26.4% |
-$50.09M +20.9% |
-$63.32M -19.9% |
-$52.79M -49.1% |
-$35.41M |
| Gross Profit | $103.01M +4.1% |
$98.94M +84.0% |
$53.77M +152.1% |
$21.33M +372.2% |
$4.52M +164.9% |
$1.71M |
| Shares Outstanding | 41.24M +2.0% |
40.43M +11.9% |
36.14M +27.8% |
28.27M +3.3% |
27.37M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $30.34M | -14.1% | -9.8% |
| Revenue (ASC 606) | September 30, 2025 | $30.34M | -14.1% | -9.8% |
| Net Income | September 30, 2025 | -$9.82M | -54.9% | +16.7% |
| Diluted EPS | September 30, 2025 | -$0.24 | -50.0% | +17.2% |
| Total Assets | September 30, 2025 | $308.53M | -0.6% | -0.2% |
| Cash and Equivalents | September 30, 2025 | $29.63M | +77.2% | -26.6% |
| Long-Term Debt | September 30, 2023 | $0.00 | -100.0% | -100.0% |
| Stockholders Equity | September 30, 2025 | $275.97M | -0.5% | -0.7% |
| R&D Expense | September 30, 2025 | $9.06M | +2.5% | -11.3% |
| Operating Income | September 30, 2025 | -$12.18M | -32.0% | +13.0% |
| Gross Profit | September 30, 2025 | $24.23M | -3.9% | -3.8% |
| Shares Outstanding | September 30, 2025 | 41.08M | +2.1% | +0.4% |
- RxSight, Inc. reported Total Revenue of $134.48 million for fiscal year 2025.
- RxSight, Inc. showed a decrease of -3.9% in Total Revenue compared to the prior fiscal year.
- RxSight, Inc. reported Revenue (ASC 606) of $134.48 million for fiscal year 2025.
- RxSight, Inc. showed a decrease of -3.9% in Revenue (ASC 606) compared to the prior fiscal year.
- RxSight, Inc. reported Net Income of -$38.94 million for fiscal year 2025.
- RxSight, Inc. showed a decrease of -41.8% in Net Income compared to the prior fiscal year.
- RxSight, Inc. reported Diluted EPS of $0.95 per share (loss) for fiscal year 2025.
- RxSight, Inc. showed a decrease of -33.8% in Diluted EPS compared to the prior fiscal year.
- RxSight, Inc. reported Total Assets of $311.81 million for fiscal year 2025.
- RxSight, Inc. showed a decrease of -2.1% in Total Assets compared to the prior fiscal year.
- RxSight, Inc. reported Cash and Equivalents of $19.95 million for fiscal year 2025.
- RxSight, Inc. showed an increase of +19.4% in Cash and Equivalents compared to the prior fiscal year.
- RxSight, Inc. reported Long-Term Debt of $0.00 for fiscal year 2023.
- RxSight, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- RxSight, Inc. reported Stockholders Equity of $275.68 million for fiscal year 2025.
- RxSight, Inc. showed a decrease of -2.0% in Stockholders Equity compared to the prior fiscal year.
- RxSight, Inc. reported R&D Expense of $38.55 million for fiscal year 2025.
- RxSight, Inc. showed an increase of +12.2% in R&D Expense compared to the prior fiscal year.
- RxSight, Inc. reported Operating Income of -$48.19 million for fiscal year 2025.
- RxSight, Inc. showed a decrease of -30.7% in Operating Income compared to the prior fiscal year.
- RxSight, Inc. reported Gross Profit of $103.01 million for fiscal year 2025.
- RxSight, Inc. showed an increase of +4.1% in Gross Profit compared to the prior fiscal year.
- RxSight, Inc. reported Shares Outstanding of 41.24 million shares for fiscal year 2025.
- RxSight, Inc. showed an increase of +2.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: